These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6752167)

  • 1. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
    Tindall GT; Kovacs K; Horvath E; Thorner MO
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathology of prolactin cell adenomas of the human pituitary.
    Horvath E; Kovacs K
    Semin Diagn Pathol; 1986 Feb; 3(1):4-17. PubMed ID: 3303229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bromocriptine for prolactin-secreting macroadenomas of the pituitary].
    Landman L; Spindel A; Tal Y; Bar-Meir A; Sharf M; Dickstein G
    Harefuah; 1987 Oct; 113(7-8):156-9. PubMed ID: 3428740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
    Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
    Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine treatment of macroprolactinomas: studies on the time course of tumor shrinkage and morphology.
    Nissim M; Ambrosi B; Bernasconi V; Giannattasio G; Giovanelli MA; Bassetti M; Vaccari U; Moriondo P; Spada A; Travaglini P; Faglia G
    J Endocrinol Invest; 1982; 5(6):409-15. PubMed ID: 7169515
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regression with purely medical treatment of pituitary prolactin adenomas].
    Bricaire H
    Ann Med Interne (Paris); 1982; 133(1):58. PubMed ID: 7065591
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in size of a pituitary tumor by bromocriptine therapy.
    McGregor AM; Scanlon MF; Hall K; Cook DB; Hall R
    N Engl J Med; 1979 Feb; 300(6):291-3. PubMed ID: 759882
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of postoperative bromocriptine treatment for prolactin-secreting pituitary adenomas].
    Sato O; Niwa J; Inoue Y; Akagawa S; Kobayashi K
    No Shinkei Geka; 1983 Jan; 11(1):51-60. PubMed ID: 6682184
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor effect of bromocriptine on estrogen-induced rat prolactinomas: ultrastructural alterations of secretory granules.
    Saitoh Y; Koizumi K; Arita N; Hayakawa T; Mogami H; Matsumoto K; Mori H
    Anticancer Res; 1986; 6(5):1149-55. PubMed ID: 3800323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
    Hubbard JL; Scheithauer BW; Abboud CF; Laws ER
    J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of prolactin-producing pituitary adenomas].
    von Werder K; Fahlbusch R; Rjosk HK
    Dtsch Med Wochenschr; 1982 Jun; 107(23):887-9. PubMed ID: 7200861
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
    Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
    Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prolactin adenoma with ophthalmological manifestations. Treatment with bromocriptine].
    Saraux H; Offret H; Brasnu C; Charpentier G
    Bull Soc Ophtalmol Fr; 1980; 80(6-7):489-93. PubMed ID: 7408092
    [No Abstract]   [Full Text] [Related]  

  • 18. Bromocriptine treatment of prolactinomas.
    von Werder K; Eversmann T; Fahlbusch R; Rjosk HK
    N Engl J Med; 1979 Jun; 300(24):1391-2. PubMed ID: 440368
    [No Abstract]   [Full Text] [Related]  

  • 19. Bromocriptine treatment of prolactinomas.
    Bergh T; Nillius SJ; Lundberg PO; Wide L
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440367
    [No Abstract]   [Full Text] [Related]  

  • 20. Bromocriptine treatment of prolactinomas.
    Aronoff SL; Daughaday WH; Laws ER
    N Engl J Med; 1979 Jun; 300(24):1391. PubMed ID: 440366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.